Jasper Therapeutics (Nasdaq: JSPR) has finalized its all-stock acquisition of Kira Pharmaceuticals, forming a combined entity focused on treatments for immune-related conditions. Alongside the...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for children aged six and older living with moderate-to-severe plaque...
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to 17 years recently diagnosed with stage...